Mutations and deletions in the IKZF1 gene, which encodes Ikaros, are particularly associated with Philadelphia positive (Ph+, also known as BCR-ABL positive) B-ALL and are present in 70-80% of these patients. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.